As a response to the Coronavirus/Covid-19 outbreak, many medical associations and organizations have released statements specifically related to treatment for cardiovascular patients.
These resources provide credible and trustworthy information. Many if not most, speak to the need for more detailed research and data, to help guide us as we develop new standards of practice to ensure optimal care based on clinical practice rather than speculation.
- Wear a mask in public places
- Social distancing - stay at least 6 feet away from other people
- Wash your hands frequently - with warm soapy water for at least 30 seconds
- Avoid crowds, confined and poorly ventilated spaces.
Congressman-Elect Dies of COVID; U.K. Variant Is Here; What's Next for Pandemic?
- Britain's Emergency Authorization of AstraZeneca vaccine
- President-Elect Joe Biden's promise to improve the speed of vaccine distribution
- LA County confirmed the highest number of hospitalizations in a single day
- External review of the case of a physician who died with COVID-19 - did racism affect her care?
- 500 doses of Moderna vaccine discarded after being left unrefrigerated at a Wisconsin hospital
- Where will year two of the pandemic take us?
- Other news
Covid vaccine: US drugs agency FDA to proceed with Pfizer approval
The US Food and Drug Administration (FDA) has come under renewed White House pressure to approve emergency use of the Pfizer-BioNTech Covid vaccine.
FDA head Stephen Hahn was told to approve it on Friday or quit, US media said, although he called this "untrue".
The spotlight fell on the FDA after its experts on Thursday supported the vaccine. The US health secretary said it should roll out in a couple of days.
The Pfizer has been approved in the UK, Canada, Bahrain and Saudi Arabia.
- What did the FDA say?
- What happens when the vaccine is approved?
- When can you get vaccinated in the US?
- Safety data on the Pfizer vaccine
- How does the Pfizer vaccine work
The experts' recommendations still have to be approved by the FDA's vaccine chief, Dr. Peter Marks, before rollout can begin.
Operation Warp Speed, the federal government's vaccine distribution program, says deliveries will begin within 24 hours of the FDA's approval.
Interim Analysis of ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2
How safe and effective is the ChAdOx1 nCoV-19 vaccine (AZD1222) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?
At a glance:
- The ChAdOx1 nCoV-19 vaccine is safe and has an efficacy ranging between 50%-90% in preventing symptomatic COVID-19 depending on the dosing regimen.
- Most participants were 18-55 years age. Efficacy in the older, higher-risk population which would benefit the most is unclear.
- While press releases from other coronavirus vaccine developers claim >90% efficacy, the impact on public health will depend on the ability to distribute and administer the vaccine at scale.
- Currently, 48 vaccines are under clinical study, of which 11 are under evaluation in phase 3 clinical efficacy studies
- Overall efficacy of the vaccine was 70%, similar to the efficacy of the flu vaccine
- The efficacy reported is in a generally low-risk population, as most of the participants were <55 years old.
- Several questions remain: What is the effectiveness in a higher-risk and older population?
- Can the vaccine prevent asymptomatic transmission?
- What is the optimal dosing regimen?
COVID Passes Heart Disease as Top US Killer
COVID-19 passed heart disease as the leading cause of death during the past week, according to the Institute for Health Metrics and Evaluation.
More than 11,800 COVID-19 deaths were reported, passing heart disease at 10,700 deaths, lung and tracheal cancer at nearly 4,000 deaths, chronic obstructive pulmonary disease at more than 3,700 deaths, and stroke at more than 3,600 deaths. The daily death rate is greater than 4 per million in 34 states, according to the report.
- The IHME estimates the number of deaths could reach more than 500,000 by April 2021
- Covid-19 data from Johns Hopkins University
- Projected vaccine rollout could save 9,000 lives by April, 2021
- Hospitals will face "high or extreme stress" for beds & ICU capacity from December to February according to IHME
- US logged more than 1 million new cases during the first five days of December
Statin Use in Patients With Diabetes Hospitalized for COVID-19 Associated with Lower Mortality
- Statin therapies and cumulative in-hospital mortality rates in patients with higher co-morbidity burdens
- Risk of death during hospitalization compared to non-statin-users
- JAMA Journals - Statin Use and In‐Hospital Mortality in Patients With Diabetes Mellitus and COVID‐19
Do you have questions about a medical case or need help understanding treatment plans and options?
Health & Patient Advocacy | Medical Expert Witness | Medical Case Review
Dalawari Medical Services - Medical Consulting
Click here to Contact Us via email or Call + (918)-699-9525